Gheuens Sarah

Chief Medical Officer

Gheuens Sarah has filed 8 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Aug 6, 2026.

On the most recent filing, Gheuens Sarah is listed as Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. Inside the rolling window, Gheuens Sarah reported no open-market purchases and 8 open-market sales totaling $1.6M in AGIO. The largest disclosed transaction in the window is a sale of 30,000 AGIO shares on Aug 4, 2026, worth $914K.

Companies traded

Other insiders at AGIO

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.6M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
AGIOSale$914KAug 6SEC ↗
AGIOSale$151KJul 2SEC ↗
AGIOSale$102KApr 6SEC ↗
AGIOSale$83KMar 3SEC ↗
AGIOSale$79KJan 2SEC ↗
AGIOSale$107KNov 13SEC ↗
AGIOSale$9KNov 3SEC ↗
AGIOSale$145KOct 29SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Gheuens Sarah made?

Gheuens Sarah has filed 8 SEC Form 4 filings (19 transaction rows) across 1 company since 2025.

Which companies does Gheuens Sarah trade?

Gheuens Sarah has filed SEC Form 4 disclosures for 1 company, including AGIO.

When was Gheuens Sarah's most recent SEC Form 4 filing?

Gheuens Sarah's most recent SEC Form 4 filing on Tracefour is dated Aug 6, 2026.

What is Gheuens Sarah's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Gheuens Sarah is listed as Chief Medical Officer.

What is Gheuens Sarah's total buy and sell value in the current window?

Inside the rolling retention window, Gheuens Sarah bought $0 and sold $1.6M based on SEC Form 4 filings.

What was Gheuens Sarah's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 30,000 AGIO shares on 2026-08-04, worth $914K, per SEC Form 4 filings.